069620.KS
069620.KS
KR7069620003
DAEWOONG PHARM
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.570.891.005.320 1.422.683.296.380
10.4%
Cost of Revenue 748.359.218.860 688.515.743.850
8.7%
Gross Profit 822.531.786.460 734.167.552.530
12.0%
625.749.372.000 586.225.354.000
6.7%
Operating Income 196.782.414.460 147.942.198.530
33.0%
Pretax Income 191.833.139.350 56.550.480.230
239.2%
Net Income Common Stockholders 195.855.574.630 24.734.510.690
691.8%
-- --
--
-- --
--
ende